$SNPS

HSBC Upgrades Synopsys to Buy, Sees 28% Earnings Growth Through 2028

HSBC upgraded Synopsys (SNPS) to Buy with a $700 price target, citing a potential shift in business model that could boost earnings growth to 28% through 2028. Synopsys reported 42% revenue growth and a $10.9B backlog last quarter, and has a new AI partnership with TSMC. Seventeen analysts raised EPS estimates in the past 30 days, with HSBC's target 28% above the Street consensus.

Original reporting
Published Sep 25, 2026, 3:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 3:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HSBC Upgrades Synopsys to Buy, Sees 28% Earnings Growth Through 2028 — source image
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

The upgrade is likely to attract growth‑oriented investors and could sustain the recent 4% pre‑market rally.

02

Market read

Analyst upgrade with a substantial price target increase provides fresh buying impetus for SNPS and may influence peer valuations in the AI‑related semiconductor software space.

03

What to watch

Customer concentration and export‑control risks could limit the upside of the new business model.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

HSBC analyst Frank Lee upgraded Synopsys (NASDAQ:SNPS) to Buy, raising the price target to $700 from $490, and highlighted a shift to a license‑plus‑royalty model tied to AI chip design.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

HSBC upgraded Synopsys to Buy with a $700 price target, citing a shift to a royalty‑based AI business model and noting a 4.38% pre‑market price rise.

Expected impact

Potential upside of 5‑10% over the next few weeks if the royalty model materializes.

Evidence & confidence

The upgrade includes a 28% earnings growth outlook to 2028 and a target price 28% above consensus, which historically moves the stock on the day of release.

Market effects

Highlights the growing importance of AI‑driven royalty models in the EDA sector, potentially prompting re‑ratings of peers.

U.S. semiconductor and software stocks may see increased interest as AI infrastructure spending accelerates.

Signals a shift in how chip design IP is monetized worldwide, relevant to global AI supply chains.

Counterpoint

The royalty model may introduce revenue volatility and execution risk, making the upgrade potentially premature.

Key entities

  • Synopsys

    Electronic design automation and semiconductor IP provider.

  • HSBC

    Investment bank providing the analyst upgrade.

Related articles

$GENIMed

Genius, CF, 3M, Nike, Synopsys Trending With Analysts

Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.

$SNPSMed

Why Synopsys Stock Popped, Then Dropped

Synopsys (SNPS) stock rose 5% then dropped 4% after Q3 earnings beat expectations, with 42.5% sales growth and 89% GAAP earnings increase. CEO Sassine Ghazi cited AI chip complexity driving demand. Analysts upgraded SNPS, with HSBC setting a $700 target based on non-GAAP earnings.